Bevacizumab biosimilar (Qilu Pharma) |
QL-1101 |
Approved |
Qilu Pharmaceutical Co Ltd |
安可达 |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Qilu Pharmaceutical Co Ltd |
2019-12-06 |
Neoplasms; Colorectal Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Innovent Biologics) |
IBI-305; IBI305; IBI 305; CHS-305 |
Approved |
Innovent Biologics(Suzhou) Co Ltd |
达攸同, BYVASDA, Bevagen |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Innovent Biologics(Suzhou) Co Ltd |
2020-06-17 |
Ovarian Neoplasms; Glioblastoma; Carcinoma, Ovarian Epithelial; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Pfizer) |
PF-6439535; PF-06439535 |
Approved |
Pfizer Inc |
Zirabev |
EU |
Carcinoma, Renal Cell; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Fallopian Tube Neoplasms |
Pfizer Europe Ma Eeig |
2019-02-14 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Elea) |
|
Approved |
Laboratorio Elea Phoenix Sa |
Lumiere |
Argentina |
Macular Degeneration |
Laboratorio Elea Phoenix Sa |
2018-04-26 |
Macular Degeneration |
Details
|
Bevacizumab biosimilar (Samsung Bioepis) |
SP-8; SB-8 |
Approved |
Samsung Bioepis Co Ltd |
Aybintio |
EU |
Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Renal Cell |
Samsung Bioepis Nl Bv |
2020-08-19 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Small Cell Lung Carcinoma; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Ranibizumab biosimilar (Samsung Bioepis) |
AM002; SB-11; SB11 |
Approved |
Samsung Bioepis Co Ltd |
BYOOVIZ |
EU |
Macular Edema; Wet Macular Degeneration; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic macular oedema; Diabetic Retinopathy |
Samsung Bioepis Nl Bv |
2021-08-18 |
Macular Edema; Diabetic macular oedema; Wet Macular Degeneration; Macular Degeneration; Diabetic Retinopathy; Choroidal Neovascularization; Retinal Vein Occlusion |
Details
|
Bevacizumab biosimilar (Intas Pharmaceuticals) |
INTP-24 |
Approved |
Intas Biopharmaceuticals |
Bevatas |
India |
Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Uterine Cervical Neoplasms; Glioblastoma; Carcinoma, Renal Cell; Breast Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms |
Intas Biopharmaceuticals |
2017-10-04 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Ranibizumab biosimilar (Formycon/Bioeq) |
FYB-201 |
Approved |
Bioeq Gmbh |
CIMERLI, Ranivisio |
United States |
Wet Macular Degeneration; Diabetic macular oedema; Macular Degeneration; Macular Edema; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic Retinopathy |
Coherus Biosciences Inc |
2022-08-02 |
Macular Edema; Wet Macular Degeneration; Diabetic macular oedema; Diabetes Complications; Macular Degeneration; Retinal Vein Occlusion; Choroidal Neovascularization; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (AryoGen Biopharma) |
BE1040V |
Approved |
Aryogen Biopharma |
Stivant |
Iran |
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Uterine Cervical Neoplasms; Metastatic breast cancer; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Glioblastoma |
Aryogen Biopharma |
2019-06-01 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Colorectal Neoplasms; Peritoneal Neoplasms; Metastatic breast cancer; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Zydus Cadila) |
|
Approved |
Zydus Cadila |
Bryxta |
India |
Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Colorectal Neoplasms; Glioblastoma; Metastatic breast cancer; Carcinoma, Renal Cell |
Zydus Cadila |
2017-01-01 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (TOT Biopharm) |
TAB-008; TOT-102; TAB008; TOT102 |
Approved |
|
朴欣汀, Pusintin |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Tot Biopharm Co Ltd |
2021-12-01 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab |
G180CU; RO-4876646; RG-435; NSC-704865; G180CL; R-435; G180DL |
Approved |
Genentech Inc |
安维汀, Avastin |
United States |
Colorectal Neoplasms |
Genentech Inc |
2004-02-26 |
Solid tumours; Liver Neoplasms; Ovarian Neoplasms; Recurrence; Infections; Respiratory Tract Infections; Pterygium; Leukemia; Arteriovenous Malformations; Ependymoma; Telangiectasia, Hereditary Hemorrhagic; HIV Infections; Leukemia, Myelogenous, Chronic; Kidney Neoplasms; Epistaxis; Head and Neck Neoplasms; Leiomyosarcoma; Fibrosarcoma; Telangiectasis; Meningeal Carcinomatosis; Rectal Neoplasms; Vaginal Neoplasms; Esophageal Neoplasms; Macular Edema; Anaplasia; Carcinoma, Renal Cell; Diabetes Mellitus, Type 2; Squamous Cell Carcinoma of Head and Neck; Abdominal Neoplasms; Granuloma, Lethal Midline; Hemangioblastoma; Carcinoma; Carcinoma, Basal Cell; Esthesioneuroblastoma, Olfactory; Carcinoid Tumor; Carcinoma, Ovarian Epithelial; Glioblastoma; Neurofibromatosis 2; Pancreatic Neoplasms; Neoplasms, Glandular and Epithelial; Virus Diseases; Papillomavirus Infections; Neoplasms, Squamous Cell; Respiratory Tract Diseases; Neoplasms; Small Cell Lung Carcinoma; Myelodysplastic Syndromes; Triple Negative Breast Neopl |
Details
|
Bevacizumab biosimilar(Dr. Reddy's Laboratories) |
DRL-BZ |
Approved |
Dr.Reddy's Laboratories Ltd |
Versavo, Persivia |
India |
Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Glioblastoma; Peritoneal Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell |
Dr.Reddy's Laboratories Ltd |
2019-08-19 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Bevacizumab biosimilar (Celltrion) |
CTP-16; CT-16; CT-P16 |
Approved |
Celltrion Inc |
Vegzelma |
EU |
Carcinoma, Renal Cell; Peritoneal Neoplasms; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Colorectal Neoplasms |
Celltrion Healthcare Hungary Kft |
2022-08-17 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Aflibercept biosimilar (Momenta/Mylan) |
M-710; MYL-1701P |
Approved |
Momenta, Mylan Nv |
|
EU |
Diabetes Complications; Myopia, Degenerative; Diabetic Retinopathy; Macular Edema; Retinal Vein Occlusion |
Viatris Ltd |
2023-09-15 |
Macular Edema; Myopia, Degenerative; Diabetic macular oedema; Diabetes Complications; Diabetic Retinopathy; Retinal Vein Occlusion |
Details
|
Ranibizumab biosimilar (Intas Biopharmaceuticals) |
|
Approved |
Intas Biopharmaceuticals |
Razumab |
India |
Macular Degeneration |
Intas Biopharmaceuticals |
2015-01-01 |
Macular Degeneration |
Details
|
Ranibizumab biosimilar (Xbrane) |
|
Approved |
Xbrane Biopharma Ab |
|
EU |
Diabetic Retinopathy; Macular Edema; Wet Macular Degeneration; Diabetes Complications |
Stada Arzneimittel Ag |
2022-11-09 |
Macular Edema; Wet Macular Degeneration; Diabetes Complications; Macular Degeneration; Diabetic Retinopathy |
Details
|
Bevacizumab biosimilar (Boan Biopharma) |
LY-01008 |
Approved |
|
博优诺, Boyounuo |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Shandong Boan Biotechnology Co Ltd |
2021-05-07 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (Shanghai Henlius Biotech) |
HLX-04; HLX04-O |
Approved |
Shanghai Henlius Biotech Inc |
汉贝泰 |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Shanghai Henlius Biopharmaceuticals Co Ltd |
2021-11-30 |
Solid tumours; Carcinoma; Rectal Neoplasms; Carcinoma, Ovarian Epithelial; Glioblastoma; Wet Macular Degeneration; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Macular Degeneration; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (Biocad) |
BCD-021 |
Approved |
Biocad |
Avegra |
Russian Federation |
Glioblastoma; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Peritoneal Neoplasms; Uterine Cervical Neoplasms |
Biocad |
2015-11-25 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Sinocelltech) |
SCT-510; SCT510A; SCT-510A |
Approved |
SinoCelltech Ltd |
安贝珠 |
Mainland China |
Peritoneal Neoplasms; Uterine Cervical Neoplasms; Ovarian Neoplasms; Fallopian Tube Neoplasms; Glioblastoma; Colorectal Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung |
SinoCelltech Ltd |
2023-06-27 |
Ovarian Neoplasms; Glioblastoma; Carcinoma, Ovarian Epithelial; Wet Macular Degeneration; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Macular Degeneration; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|
Ranibizumab biosimilar (Qilu Pharmaceutical) |
BCD-300; QL-1205 |
Approved |
Biocnd, Qilu Pharmaceutical Co Ltd |
Rimmyrah |
EU |
Myopia, Degenerative; Choroidal Neovascularization; Diabetes Complications; Macular Edema; Wet Macular Degeneration |
Qilu Pharma Spain Sa |
2024-01-05 |
Macular Edema; Myopia, Degenerative; Wet Macular Degeneration; Diabetic macular oedema; Diabetes Complications; Retinal Vein Occlusion; Macular Degeneration; Choroidal Neovascularization; Diabetic Retinopathy; Myopia |
Details
|
Bevacizumab biosimilar (Allergan/Amgen) |
ABP-215 |
Approved |
Amgen Inc |
Mvasi |
United States |
Glioblastoma; Carcinoma, Renal Cell; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Amgen Inc |
2017-09-14 |
Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Aflibercept biosimilar (Qilu Pharmaceutical) |
QL-1207 |
Approved |
Qilu Pharmaceutical Co Ltd |
|
Mainland China |
Macular Degeneration; Diabetic macular oedema |
Qilu Pharmaceutical Co Ltd |
2023-12-13 |
Diabetic macular oedema; Macular Degeneration |
Details
|
Ranibizumab biosimilar (Senju) |
GBS-007; OT-701; SJP-0133 |
Approved |
Senju Pharmaceutical Co Ltd |
|
Japan |
Macular Degeneration |
Senju Pharmaceutical Co Ltd |
2021-09-27 |
Wet Macular Degeneration; Macular Degeneration |
Details
|
Bevacizumab biosimilar (mAbixience) |
MB02; BEVZ-92; BEVZ92-MB02; AP-01 |
Approved |
Mabxience Sa |
Alymsys |
Argentina |
Colorectal Neoplasms; Carcinoma, Renal Cell; Peritoneal Neoplasms; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms |
Stada Arzneimittel Ag |
2013-10-25 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Neovasculgen |
PI-VEGF165 |
Approved |
Human Stem Cells Institute |
Neovasculgen |
Russian Federation |
Peripheral Arterial Disease |
Human Stem Cells Institute |
2011-12-07 |
Peripheral Arterial Disease; Peripheral Nerve Injuries |
Details
|
Bevacizumab biosimilar (CTTQ Pharma) |
TQ-B2302 |
Approved |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd |
安倍斯 |
Mainland China |
Glioblastoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group |
2023-02-28 |
Ovarian Neoplasms; Glioblastoma; Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Bevacizumab biosimilar (Biocon/Mylan) |
MYL-1402O |
Approved |
Biocon Ltd |
Lextemy, KRABEVA, Abevmy |
India |
Carcinoma, Renal Cell; Colorectal Neoplasms; Ovarian Neoplasms; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Mylan Pharmaceuticals Private Ltd |
2017-11-27 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Breast Neoplasms; Brain Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Conbercept |
FP-3; KH-902 |
Approved |
Chengdu Kanghong Biotechnologies Co Ltd |
朗沐, Langmu |
Mainland China |
Macular Degeneration |
Chengdu Kanghong Biotechnologies Co Ltd |
2013-11-27 |
Macular Edema; Vision Disorders; Wet Macular Degeneration; Diabetic macular oedema; Retinoblastoma; Hemangioma; Uveitis; Retinal Vein Occlusion; Choroidal Neovascularization; Corneal Neovascularization; Diabetes Mellitus; Macular Degeneration |
Details
|
Bevacizumab biosimilar(Apotex ) |
|
Approved |
Apotex Inc |
BAMBEVI |
Canada |
Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Glioblastoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Apotex Inc |
2021-09-23 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Aflibercept |
BAY-865321; BAT-86-5321 |
Approved |
Bayer AG |
Eylea, 艾力雅 |
United States |
Macular Degeneration; Macular Edema |
Regeneron Pharmaceuticals Inc |
2011-11-18 |
Retinitis Pigmentosa; Choroidal Neovascularization; Carcinoma, Non-Small-Cell Lung; Corneal Neovascularization; Retinopathy of Prematurity; Neoplasm Metastasis; Diabetic Retinopathy; Retinal Vein Occlusion; Macular Degeneration; Vitreous Hemorrhage; Lymphoma, Non-Hodgkin; Retinal Degeneration; Eye Diseases; Diabetes Complications; Colorectal Neoplasms; Prostatic Neoplasms; Diabetes Mellitus, Type 1; Wet Macular Degeneration; Diabetic macular oedema; Multiple Myeloma; Myopia, Degenerative; Retinal Diseases; Colonic Neoplasms; Central Serous Chorioretinopathy; Neoplasms; Diabetes Mellitus, Type 2; Rectal Neoplasms; Choroid Diseases; Glaucoma, Neovascular; Macular Edema; Cataract |
Details
|
Bevacizumab biosimilar (Jiangsu Hengrui Medicine) |
BP-102 |
Approved |
Jiangsu Hengrui Medicine Co Ltd |
艾瑞妥 |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Suzhou Suncadia Biopharmaceuticals Co Ltd |
2021-06-22 |
Solid tumours; Triple Negative Breast Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Ziv-aflibercept |
BAY-865321; AVE-0005 |
Approved |
Sanofi |
Zaltrap |
United States |
Colorectal Neoplasms |
Sanofi-Aventis U.S. Llc |
2012-08-03 |
Lymphoma; Breast Neoplasms; Urethral Neoplasms; Brain Neoplasms; Colorectal Neoplasms; Genital Neoplasms, Female; Carcinoma, Mucoepidermoid; Gliosarcoma; Astrocytoma; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Peritoneal Neoplasms; Ureteral Neoplasms; Lung Neoplasms; Prostatic Neoplasms; Uterine Neoplasms; Endometrial Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Neuroendocrine; Glioma; Lymphoma, Non-Hodgkin; Thyroid Neoplasms; Carcinoma, Squamous Cell; Retinal Vein Occlusion; Neoplasm Metastasis; Melanoma; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Solid tumours; Leiomyosarcoma; Multiple Endocrine Neoplasia Type 1; Leukemia; Carcinoma; Carcinoma, Renal Cell; Carcinoid Tumor; Rectal Neoplasms; Neoplasms; Carcinoma, Ovarian Epithelial; Pancreatic Neoplasms; Leukemia, Myelomonocytic, Chronic; Ovarian Neoplasms; Myelodysplastic Syndromes; Myeloproliferative Disorders; Carcinoma, Transitional Cell; Carcinoma, Papillary; Small Cell Lung Carcinoma; Colonic Neoplasms; Ascites; Lung Diseases; Adenoc |
Details
|
Ranibizumab |
RG-3645; rhu-Fab-VEG; AMD-rhuFab-V2; AMD-Fab; rhuFab-V2; RFB-002; Y-0317; RG-6321 |
Approved |
Novartis Pharma Ag, Genentech Inc |
Lucentis, 诺适得, Susvimo |
United States |
Macular Degeneration |
Genentech Inc |
2006-06-30 |
Retinal Degeneration; Wet Macular Degeneration; Retinoblastoma; Vascular Diseases; Glaucoma; Retinal Detachment; Diabetes Complications; Pseudoxanthoma Elasticum; Retinal Neovascularization; Cardiovascular Diseases; Eye Diseases; Uveitis; Ischemia; Vitreous Hemorrhage; Hemangioma; Retinopathy of Prematurity; Diabetic Retinopathy; Choroidal Neovascularization; Retinal Vein Occlusion; Macular Degeneration; Melanoma; Conjunctival Neoplasms; Port-Wine Stain; Corneal Neovascularization; von Hippel-Lindau Disease; Myopia; Diabetes Mellitus; Telangiectasis; Cataract; Pterygium; Polypoidal choroidal vasculopathy; Diabetic Angiopathies; Retinal Telangiectasis; Vitreous Detachment; Epistaxis; Telangiectasia, Hereditary Hemorrhagic; Iris Diseases; Vision Disorders; Macular Edema; Glaucoma, Neovascular; Optic Neuropathy, Ischemic; Strongyloidiasis; Neovascularization, Pathologic; Depression; Central Serous Chorioretinopathy; Histoplasmosis; Retinal Diseases; Angioid Streaks; Myopia, Degenerative; Pathologic Processes; Mu |
Details
|
Bevacizumab biosimilar (Reliance Life Sciences) |
R-TPR-023 |
Approved |
Reliance Life Sciences |
BevaciRel |
India |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Carcinoma, Renal Cell; Fallopian Tube Neoplasms; Carcinoma, Ovarian Epithelial; Peritoneal Neoplasms; Uterine Cervical Neoplasms |
Reliance Life Sciences Pvt Ltd |
2016-06-13 |
Carcinoma, Renal Cell; Glioblastoma; Carcinoma, Ovarian Epithelial; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms |
Details
|
Faricimab |
RO-6867461; RG-7716 |
Approved |
F. Hoffmann-La Roche Ltd, Genentech Inc |
Vabysmo, 罗视佳 |
United States |
Diabetic macular oedema; Wet Macular Degeneration |
Genentech Inc |
2022-01-28 |
Polypoidal choroidal vasculopathy; Macular Edema; Choroid Diseases; Vision Disorders; Retinal Diseases; Diabetic macular oedema; Wet Macular Degeneration; Diabetes Complications; Macular Degeneration; Diabetes Mellitus; Retinal Vein Occlusion; Diabetic Retinopathy; Choroidal Neovascularization |
Details
|
Bevacizumab biosimilar (Hetero Drugs) |
|
Approved |
Hetero Drugs Ltd |
Cizumab |
India |
Colorectal Neoplasms |
Hetero Drugs Ltd |
2016-06-27 |
Colorectal Neoplasms |
Details
|
Bevacizumab biosimilar (Bio-Thera Solutions) |
BAT-1706 |
Approved |
Bio-Thera Solutions Ltd |
普贝希, AVZIVI |
Mainland China |
Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms |
Bio-Thera Solutions Ltd, Beigene Ltd |
2021-11-17 |
Ovarian Neoplasms; Carcinoma, Renal Cell; Carcinoma, Ovarian Epithelial; Glioblastoma; Neoplasms; Breast Neoplasms; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Hepatocellular |
Details
|
Bevacizumab biosimilar (Betta/Mabworks) |
MIL-60 |
Approved |
Institute Of Basic Medicine, Chinese Academy Of Medical Sciences, Beijing Mabworks Biotech Co Ltd |
贝安汀 |
Mainland China |
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Betta Pharmaceuticals Co Ltd |
2021-11-24 |
Carcinoma, Ovarian Epithelial; Glioblastoma; Peritoneal Neoplasms; Colorectal Neoplasms; Fallopian Tube Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular |
Details
|